Outcome of neurofibromatosis type 1 patients treated with first line vinblastine for optic pathway gliomas: A Canadian multicenter study.
Álvaro Lassaletta(Hospital for Sick Children), Éric Bouffet(Hospital for Sick Children), Ute Bartels(Hospital for Sick Children), Katrin Scheinemann(University of Lucerne), Ella Barlev(Hospital for Sick Children), Gregory R. Pond(Juravinski Hospital), Beverley Wilson, Ken Poskitt, Shayna Zelcer(London Health Sciences Centre), Donna L. Johnston(Children's Hospital of Eastern Ontario), Lucie Lafay Cousin(Alberta Children's Hospital), Cynthia Hawkins(Hospital for Sick Children), Nada Jabado(McGill University), Daniel Keene, Valérie Larouche, Uri Tabori(Universität Hamburg), Anne Sophie Carret(St Nicholas Hospital), Juliette Hukin(BC Children's Hospital)
Cited by 1
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795